Industry News
In multiple myeloma patients, unprecedented benefit seen in test of three-drug treatment
Dec 10, 2014
In the treatment of multiple myeloma, the addition of carfilzomib to a currently accepted two-drug combination produced significantly better results than using the two drugs alone, according to a... Read More
Prognostic tool for multiple myeloma may be provided by circulating RNA
Dec 10, 2014
The "molecular mail" sent by multiple myeloma cells provides clues to how well patients with the disease are likely to respond to treatment, according to a study presented at the annual meeting of... Read More
New targets for therapy identified for chronic lymphocytic leukemia
Dec 10, 2014
Chronic lymphocytic leukemia (CLL) is among the most frequent leukemias affecting adults in Western countries. Read More
Robotic surgery can now treat previously inoperable tumors
Dec 10, 2014
Head and neck cancer tumors previously unreachable can be treated with a groundbreaking new surgery method that is also minimally invasive. Read More
Scientists chart spinal circuitry responsible for chronic pain
Dec 10, 2014
Findings could lead to new therapeutics for disorders such as fibromyalgia and phantom limb painPain typically has a clear cause - but not always. Read More
Injectable, self-assembling structures 'could fight cancer'
Dec 09, 2014
Harvard researchers report success in using self-assembling, biodegradable mesoporous silica rods - loaded with immune system-triggering drugs - to treat disease in mice. Read More
Age-linked gene changes underlie therapy-related leukemia in cancer patients
Dec 09, 2014
New study finds - contrary to current thinking - a leukemia that can follow cancer treatment is linked to age-related gene mutations in cells that resist treatment then multiply. Read More
Cornerstone Pharmaceuticals commences Phase I clinical trial of CPI-613 for the treatment of B-cell Non-Hodgkin lymphoma
Dec 09, 2014
Cornerstone Pharmaceuticals, Inc., a clinical stage company and leader in the growing field of cancer metabolism-based therapeutics, has announced the initiation of a Phase I clinical trial... Read More
Scottish Medicines Consortium says 'yes' to new blood cancer drug
Dec 09, 2014
From 8 December 2014, patients in Scotland with chronic lymphocytic leukaemia (CLL) could benefit from Gazyvaro, which has been given the green light by the Scottish Medicines Consortium (SMC) for... Read More
Study offers future hope for tackling signs of ageing
Dec 09, 2014
A new advance in biomedical research at the University of Leicester could have potential in the future to assist with tackling diseases and conditions associated with ageing - as well as in... Read More
Previous Page Next Page